CrushSCI.com
117.7Average days
99Median days
13Fastest days
251Longest days
4462025 publications

Paper Review Records

All Paper Review Records

27 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

150 days

Temperature Variation‐Triggered TRPA1 Activation Induces Intranuclear IL ‐33 Expression in Trigeminal Ganglion Neurons to Provoke Nasal Hypersensitivity in Idiopathic Rhinitis

Authors
Jinqi Lang; Cuida Meng; Yongtai Wang; Jiani Li; Xi Chen; Liwei Sun; Weizheng Zhao; Ju Qiu; Dongdong ZhuShow moreShow less
Affiliations
1. The Department of Otolaryngology Head and Neck Surgery China‐Japan Union Hospital of Jilin University Changchun China; 2. Jilin Provincial Key Laboratory of Diagnosis and Treatment of Upper Airway Allergic Diseases Changchun China; 3. Otolaryngology Head and Neck Surgery Research Center Changchun China; 4. The Shanghai Institute of Nutrition and Health University of the Chinese Academy of Sciences Shanghai China; 5. Innovation Center of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education Shanghai ChinaShow moreShow less
Source PDF DOI Publisher page
43 days

The Allergic Map: Clinical Trajectories, Immune Heterogeneity, and Precision Intervention

Authors
David A. Hill; Cezmi A. AkdisShow moreShow less
Affiliations
1. Division of Allergy and Immunology Children's Hospital of Philadelphia Philadelphia Pennsylvania USA; 2. Institute for Immunology and Immune Health and Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA; 3. Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich Davos SwitzerlandShow moreShow less
Source PDF DOI Publisher page
75 days

Allergen‐Specific Antibodies Dysregulation and Profiles in IgG4 ‐Related Disease: A Hybrid Case–Control and Cross‐Sectional Study

Authors
Lu Lyu; Zhiyuan Zhang; Yi Liu; Jing Zhang; Boyuan Sun; Yi Sun; Shandong Wu; Xiaoping Xia; Liangyu Xia; Zhang Wen; Jinlyu SunShow moreShow less
Affiliations
1. Department of Allergy State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Precision Medicine for Diagnosis and Treatment of Allergic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 2. Department of Medical Care Department Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China; 3. Hangzhou Zheda Dixun Biological Gene Engineering Co., Ltd. Hangzhou China; 4. Department of Rheumatology National Clinical Research Center for Dermatologic and Immunologic Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College Beijing China; 5. Department of Rheumatology and Immunology Peking University Third Hospital Beijing China; 6. School of Medical Technology and Information Engineering Zhejiang Chinese Medical University Hangzhou China; 7. Department of Clinical Laboratory the Fourth Affiliated Hospital, Zhejiang University School of Medicine Yiwu Zhejiang China; 8. Department of Laboratory Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing ChinaShow moreShow less
Source PDF DOI Publisher page
163 days

Omalizumab Is Associated With Successful Oral Immunotherapy After Failure in Severe Pediatric Food Allergy

Authors
Letizia Ciliberti; Simona Barni; Claudia Valleriani; Lucrezia Sarti; Giulia Liccioli; Leonardo Tomei; Gabriele Simonetti; Francesco Catamerò; Mattia Giovannini; R. Sharon Chinthrajah; Francesca MoriShow moreShow less
Affiliations
1. Allergy Unit Meyer Children's Hospital IRCCS Florence Italy; 2. Department of Health Sciences University of Florence Florence Italy; 3. Immunology Laboratory Meyer Children's Hospital IRCCS Florence Italy; 4. Sean N. Parker Center for Allergy and Asthma Research Stanford University Stanford California USAShow moreShow less
Source PDF DOI Publisher page
193 days

An Extended Transcriptomic Landscape of Human Skin Mast Cells: Unveiling Lineage‐Specific Noncoding RNA Dynamics in FcεRI Activation

Authors
Gürkan Bal; Kristin Franke; Stefan Frischbutter; Shiva Raj Tripathi; Kayoko Yasuzawa; Jordan A. Ramilowski; Michihira Tagami; Takeya Kasukawa; Michiel de Hoon; Jay W. Shin; Piero Carninci; Torsten Zuberbier; Magda BabinaShow moreShow less
Affiliations
1. Institute of Allergology Charité – University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany; 2. Immunology and Allergology Fraunhofer Institute for Translational Medicine and Pharmacology ITMP Berlin Germany; 3. Center for Integrative Medical Sciences RIKEN| Yokohama Japan; 4. Advanced Medical Research Center Yokohama City University Yokohama Japan; 5. Genome Institute of Singapore Agency for Science, Technology and Research Singapore Singapore; 6. Human Technopole Milan ItalyShow moreShow less
Source PDF DOI Publisher page
13 days

Biologicals at the Allergy–Cancer Interface: Advancing AllergoOncology Through Bidirectional Precision Medicine—An EAACI Editorial

Authors
Denisa Ferastraoaru; Leticia De Las Vecillas Sanchez; Alessandra Vultaggio; Sophia N. Karagiannis; Christoph BergmannShow moreShow less
Affiliations
1. Albert Einstein College of Medicine/Montefiore Medical Center Bronx New York USA; 2. Department of Allergy La Paz University Hospital Research Institute (IdiPAZ), La Paz University Hospital Madrid Spain; 3. Department of Experimental and Clinical Medicine University of Florence Florence Italy; 4. Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London Guy's Cancer Centre London UK; 5. St. John's Institute of Dermatology, School of Basic and Medical Biosciences & KHP Centre for Translational Medicine King's College London London UK; 6. HNO RKM740 Interdisciplinary Specialist Clinic Düsseldorf GermanyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does ALLERGY take to review a manuscript?

As of 2026-11-17, CrushSCI has 27 complete review records for ALLERGY. The fastest paper went from submission to acceptance in 13 days (Biologicals at the Allergy–Cancer Interface: Advancing AllergoOncology Through Bidirectional Precision Medicine—An EAACI Editorial, received 2026-10-04, accepted 2026-10-17); the slowest took 251 days. The average is 117.7 days and the median is 99 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.